Caitong International Asset Management Co., LTD Phathom Pharmaceuticals, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 179 shares of PHAT stock, worth $1,032. This represents 0.0% of its overall portfolio holdings.
Number of Shares
179
Previous 179
-0.0%
Holding current value
$1,032
Previous $1.45 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PHAT
# of Institutions
157Shares Held
68.6MCall Options Held
52.3KPut Options Held
635K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.1MShares$58.3 Million4.92% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$43.1 Million13.31% of portfolio
-
Jennison Associates LLC7.06MShares$40.8 Million0.04% of portfolio
-
Invesco Ltd. Atlanta, GA3.67MShares$21.2 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$20.2 Million28.4% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $226M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...